Keywords: AML, acute myeloid leukemia; GVA, graft versus autoimmune; GvHD, graft-versus-host disease; HSCT, hematopoietic stem cell transplantation; Th1, helper T cell 1; allograft; cutaneous sarcoidosis; remission; stem cell transplantation; treatment.